ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00507065
Recruitment Status : Completed
First Posted : July 25, 2007
Last Update Posted : March 5, 2015
Sponsor:
Information provided by:
Shire